Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
GATA binding protein 3 (GATA3) is a member of the GATA family of transcription factors, characterized by their ability to bind the DNA consensus sequence 5'-AGATAG-3'. It plays a critical role in embryonic development, cell differentiation, and immune system regulation. GATA3 acts as a master regulator for T-helper type 2 (Th2) cell lineage commitment and is essential for the development and function of various organs and tissues. Dysregulation of GATA3 is implicated in diseases such as breast cancer and immunodeficiencies. It also negatively regulates adipogenesis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on GATA Binding Protein 3.